Navigation Links
SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results
Date:3/11/2009

346 General and administrative 1,114,034 1,248,987 4,356,647 4,554,906 Facility Lease termination Gain from lease buyout - - (4,100,000) - Expenses related to relocation and lease buyout - - 116,867 - Total facility lease buyout - - (3,983,133) - Total operating expenses 3,121,645 3,870,027 7,314,341 13,259,948 Loss from operations (2,944,760) (3,647,693) (6,356,021) (11,288,165) Other income (expense) Interest expense (2,917) (4,757) (14,482) (15,724) Interest income 24,308 131,609 229,837 682,010 Other (1,091) - 238 2,941 20,300 126,852 215,593 669,227 Net Loss $(2,924,460) $(3,520,841) $(6,140,428) $(10,618,938) Net loss per share, basic and diluted $(0.07) $(0.09) $(0.15) $(0.28) Shares used in calculation of basic and diluted net loss per share 41,043,770 38,986,882 41,038,797 38,348,560


'/>"/>
SOURCE SCOLR Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. SCOLR Pharma, Inc. Schedules Second Quarter 2008 Financial Results Conference Call for August 7, 2008 at 11:30 A.M. Eastern
2. SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
3. SCOLR Pharma, Inc. to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
4. FDA Issues Complete Response Letter to SCOLR Pharmas Abbreviated New Drug Application for CDT(R) 12-Hour Pseudoephedrine
5. GeoPharma, Inc. Receives FDA Approval to Manufacture and Distribute Carprofen
6. Novo Nordisk Inc. Announces Exclusive Agreement With Sciele Pharma, Inc. to Market Prandin(R)
7. China Biopharma, Inc. Announces New Plan of Operation
8. Meritage Pharma, Inc. Announces Company Formation and $22.5M Series A Financing
9. CB1400, Patented by Canopus BioPharma, Prevents Tumor Growth and Enhances the Anti-Tumor Effects of Cisplatin and Cetuximab (Erbitux).
10. Zosano Pharma, Inc. Announces Appointment of Gail Schulze as Chair and CEO
11. Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... -- Amici Procurement Migrates to the Cloud ... has chosen Microsoft Cloud Solution Provider iomart ...      (Logo: http://photos.prnewswire.com/prnh/20121126/579634) , ... the bio-tech sector with a unique procurement service, helping ... help them obtain best value. Its IT platform hosts ...
(Date:7/1/2015)... Mesa, CA (PRWEB) , ... July 01, 2015 , ... ... traumatic brain injury (TBI) using single photon emission computed tomography (SPECT) according ... The study, which examined over 20,000 brain scans and is believed to be ...
(Date:7/1/2015)... ... July 01, 2015 , ... The next-generation sequencing (NGS) clinical market is ... the molecular diagnostics industry. BCC Research reveals in its new report that the market ... costs, and a growing need for better diagnostics as part of a molecular diagnostics ...
(Date:7/1/2015)... 2015  Axovant Sciences Ltd. (NYSE:  AXON), a ... of dementia, today announced that the company will ... 5:45 p.m. EDT following its presentation of RVT-101 ... 2015 (AAIC). The event will ... Lawrence Friedhoff , Chief Development Officer, will ...
Breaking Biology Technology:Biotech Procurement Company Moves to Office 365 with iomart 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 4NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 3Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3
... Exchange Symbol: MS , , EDMONTON, July 17 /PRNewswire-FirstCall/ ... the treatment of multiple sclerosis (MS), today announced financial and ... 30, 2009. , "The pivotal phase III MAESTRO-01 trial has ... results from this study within the second half of this ...
... , , COLUMBIA, Md., July 17 ... of DHA, Martek Biosciences (Nasdaq: MATK ), announced today that ... The Food Chain and Animal Health (SCFCAH) of the European Union for ... , This is a significant action that will ...
... Minn., July 17 John H. Wang has been named ... several new Sanford Rose Associates executive search offices opening in ... at CircuLite, Inc. With a 30-year career in the medical ... a natural fit to spearhead the Life Science industry practice ...
Cached Biology Technology:BioMS Medical announces second quarter 2009 results 2BioMS Medical announces second quarter 2009 results 3BioMS Medical announces second quarter 2009 results 4BioMS Medical announces second quarter 2009 results 5BioMS Medical announces second quarter 2009 results 6BioMS Medical announces second quarter 2009 results 7BioMS Medical announces second quarter 2009 results 8BioMS Medical announces second quarter 2009 results 9EU Committee Approves New Food Applications for Martek's life'sDHA(TM) 2EU Committee Approves New Food Applications for Martek's life'sDHA(TM) 3Sanford Rose Associates Opens Minneapolis Office 2
(Date:6/23/2015)... June 23, 2015   MedNet Solutions , ... the entire spectrum of clinical research, is pleased ... ™ , the company,s intuitive, flexible and affordable ... Silver 2015 Stevie® Award by the American ... Services Website category.  The American Business Awards are ...
(Date:6/18/2015)... , June 18, 2015 NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market announces that its ... segment on "Money on the Mark", scheduled to air on ... June 20 th . The broadcast ... from 7:00 to 8:00pm EST. NXT-ID, Inc.,s CEO Gino ...
(Date:6/16/2015)... CITY , June 16, 2015 /CNW Telbec/ ... their partnership centralized around the incorporation of handyem,s ... point-of-care diagnostic laboratory, the Mo-POD™. This unprecedented model ... BIO International Conference at the Pennsylvania ... from June 15 th to 18 ...
Breaking Biology News(10 mins):MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 2handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 3
... University of Oklahoma WATER Center, researchers are working to provide ... According to Center Director David Sabatini, 1 billion people ... which leads to 2 million deaths a year. Located ... OU WATER Center relies on Sabatini,s expertise in physiochemical processes ...
... New Rochelle, NY, May 19, 2010Living wills often ... faced with real end-of-life circumstances and should be redesigned ... study published in Journal of Palliative Medicine , ... ). Journal of Palliative Medicine is the ...
... This release is available in Spanish . ... time adult cells extracted from a human heart to turn ... words, they achieved to "reprogram" adult stem cells, which might ... use of stem cells in treatments for heart disease is ...
Cached Biology News:OU WaTER Center researchers providing solutions in developing countries 2Living wills are poor predictors of actual treatment preferences at the end of life 2Reprogram stem cells with heart tissue, which might improve treatments for heart disease 2
... creates a new category for MALDI. It ... has been licensed to the PerkinElmerSCIEX joint ... As the first single MALDI-TOF mass spectrometer ... the prOTOF 2000 represents a substantial leap ...
Rat Aortic Endothelial Cells (RAOEC) (>500,000 cells)...
... The miVac Duo is suitable for use ... volatile organic solvents through to water and ... ,A centrifugal concentrator capable of removing water ... sample formats including tubes, microplates, vials and ...
37-1A9...
Biology Products: